期刊文献+

2型糖尿病患者血清脂联素、内脂素水平的变化 被引量:4

Changes of serumadiponectinand visfatinlevelson patient with type 2 diabetes
暂未订购
导出
摘要 目的探讨2型糖尿病(T2DM)患者血清脂联素、内脂素水平的变化及影响。方法我院初次诊断的T2DM患者共55例(T2DM组)和健康对照组50例,分别测定患者空腹血糖(FPG)、胰岛素(FINS)、糖化血红蛋白(HbAlc),血脂、脂联素和内脂素水平,并计算胰岛素抵抗指数(HOMA-IR)的变化。结果 (1)T2DM患者胰岛素抵抗指数明显增高(P<0.01);(2)T2DM患者TC、TG明显增高,HLD-C明显降低(P<0.05);(3)T2DM患者血清脂联素明显降低,内脂素水平明显增高(P<0.01);血清脂联素与内脂素呈负相关(P<0.01)。结论 T2DM患者血清脂联素和内脂素水平的变化,可能与T2DM发生、发展相关。 Objective To explore the changes and influence on serum adiponectin and visfatin levels of patients with type 2 diabetes. Methods 105 patients of initial diagnosis of T2DM in our hospital were randomly divided into two groups: the T2DM group(50 cases) and the controls group(55 cases) ,which were measured the contents of FBG, PBG, HbA1C, FINS, adiponectin and visfatin. Besides, HOMA-IR was also measured. Results ( 1 ) The HOMA-IR of patient with T2DM raised significantly (P 〈 0. 01 ) ; (2) The contents of TC and TG were increased obviously, and HLD-C was significantly decreased ( P 〈 0. 05 ) ; (3) The serum adiponectin level decreased sharply and level of visfatin increased significantly in patients with T2DM( P 〈0.01 ). The serum adiponectinlevel was negative correlated with visfatin (P 〈 0. 01 ). Conclusions The change of serum adiponeetinand visfatin levels on patient with type 2 diabetes maybe correlate with T2DM "s occurrence and development.
作者 李伟
出处 《齐齐哈尔医学院学报》 2013年第10期1411-1412,共2页 Journal of Qiqihar Medical University
关键词 2型糖尿病(T2DM) 脂联素 内脂素 Type 2 Diabetes Mellitus (T2DM) Adiponectin Visfatin
  • 相关文献

参考文献10

二级参考文献64

  • 1李光伟,潘孝仁,Peter H.Bennett.血浆葡萄糖、胰岛素比值是可靠的胰岛素敏感性指数吗?[J].中华心血管病杂志,1996,24(1):57-62. 被引量:85
  • 2范萍,刘秉文,方定志,张荣爵,刘宇,傅明德.内源性高甘油三酯血症存在胰岛素抵抗[J].中国动脉硬化杂志,1996,4(2):104-107. 被引量:10
  • 3Flier JS.The miss link with obesity? Natrue, 2001, 409:292-293
  • 4Shuldiner AR, Yang R, Gong DW.Resistin, obesity, and insulin resistance-the emerging role of the adipocyte as an endocrine organ.N Engl J Med, 2001, 345 (18):1 345-346
  • 5Weyer C, Funahashi T, Tanaka S, et al.Hypoadiponectinemia in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia.J Clin Endocrinol Metab, 2001, 86 (5):1 930-935
  • 6Yang WS, Lee WJ, Funahashi T, et al.Weight reduction increased plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.J Clin Endocrinol Metab, 2001, 86 (8):3 815-819
  • 7Steppan CM, Bailey ST, Bhat S, et al.The hormone resistin links obesity to diabetes.Nature, 2001, 409:307-331
  • 8Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin : aprotein secreted by visceral fat that mimics the effects ofinsulin [ J ]. Science,2005,307 ( 5 708 ) :426 - 430.
  • 9World Health Organization. Obesity: Preventing andManaging the Global Epidemic : Report a WHO consul-tation[ R]. WoAd Health Organ Tech Rep Ser, 2000,894 : 1 - 253.
  • 10Haider DG, Schindler K, Schaller G, et al. Increasedplasnm visfatin concentrations in morbidly obese sub-jects are reduced after gastric banding[ J ]. J Clin Endo-crinol Metab,2006,91 (4) :1 578 - 1 581.

共引文献57

同被引文献24

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部